Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Advanced Proteome Therapeutics Corporation APTCF


Primary Symbol: V.APC.H

Healthcare Biotechnology
Advanced Proteome Therapeutics Corporation is actively seeking additional funds to advance its core technologies for partnering and other potential revenue streams. It is not engaged in any activity.

Recent & Breaking News (TSXV:APC.H)

Canadian Investment Regulatory Organization Trading Halt - APC.H

Canada NewsWire December 5, 2023

Advanced Proteome Therapeutics to Proceed with Its Proposed Plan of Arrangement

Newsfile March 6, 2023

IIROC Trading Resumption - APC

Canada NewsWire January 17, 2023

Advanced Proteome Therapeutics Announces Its Proposed Plan of Arrangement

Newsfile January 17, 2023

IIROC Trading Halt - APC

Canada NewsWire January 17, 2023

Advanced Proteome Therapeutics (TSXV:APC) closes non-brokered private placement

John Ballem  December 28, 2022

Advanced Proteome Therapeutics Announces Closing of Non-Brokered Private Placement

Newsfile December 23, 2022

Advanced Proteome Therapeutics Announces Appointment of Mr. Cory Brandolini to the Board of Directors

Newsfile November 21, 2022

Advanced Proteome Therapeutics (TSXV:APC) subsidiary featured in a peer-reviewed publication

Brieanna McCutcheon  August 17, 2022

Advanced Proteome Therapeutics Manuscript Published in Bioconjugate Chemistry

Newsfile August 17, 2022

Advanced Proteome Therapeutics (TSXV:APC) issued patent

John Ballem  August 3, 2022

Advanced Proteome Therapeutics Receives Issued Patent

Newsfile August 3, 2022

Advanced Proteome (TSXV:APC) receives notice of allowance for patent claims

Caroline Egan  April 13, 2022

Advanced Proteome Therapeutics Receives Notice of Allowance for Patent Claims

Newsfile April 13, 2022

Advanced Proteome Therapeutics Announces Warrant Extension

Newsfile March 18, 2022

Advanced Proteome Therapeutics Update on Plans for 2022

Newsfile February 3, 2022

Advanced Proteome Therapeutics Expands Operations

Caroline Egan  November 23, 2021

Advanced Proteome Therapeutics Expands Operations

Newsfile November 23, 2021

Advanced Proteome Therapeutics Technology Featured in Oral Presentation at the World Molecular Imaging Congress

Newsfile October 4, 2021

Advanced Proteome Therapeutics (TSXV:APC) provides update on COVID program

John Ballem  August 24, 2021